Open AccessPerioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial
Author(s) -
Lin Cai,
De-jiao Bai,
Huipin Yuan,
Kun Wang,
GuoXun Yang,
Ming-Bai Hu,
Zhou-Qing Wu,
Yan Li
Publication year - 2004
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v10.i1.136
Subject(s) - medicine , tumor infiltrating lymphocytes , perioperative , immunology , cancer , monoclonal antibody , antibody , gastroenterology , immunotherapy , surgery
To study the effects of perioperative administration of cimetidine (CIM) on peripheral blood lymphocytes, natural killer (NK) cells and tumor infiltrating lymphocytes (TIL) in patients with gastrointestinal (GI) cancer.